Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
910 Ergebnisse
| GV70Q7 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,182 % | 0,762 | -0,021 | 6,402 | 18.09.2026 | 0,010 | Goldman Sachs | ||
| GU3T4L | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,556 % | 0,705 | -0,014 | 4,213 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW3979 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,822 % | 0,698 | -0,008 | 2,599 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW644G | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | - | 1,000 | 0,000 | 12,558 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW72V3 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,510 % | 0,685 | -0,012 | 3,805 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW730H | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 49,325 % | 0,744 | -0,034 | 7,329 | 21.08.2026 | 0,010 | Goldman Sachs | ||
| GW85DW | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,613 % | 0,703 | -0,017 | 4,665 | 20.11.2026 | 0,010 | Goldman Sachs | ||
| GW8SYC | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,206 % | 0,707 | -0,007 | 2,360 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW8SYQ | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,642 % | 0,696 | -0,010 | 3,253 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW9AJ7 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 720,000 | 15,083 % | - | - | - | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GW9AJH | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 750,000 | - | - | - | - | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GW9AJP | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 700,000 | 21,799 % | - | - | - | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GW9AK6 | Regeneron Pharmaceuticals Inc./OS/Call [600]/GOLDS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 680,000 | 24,936 % | - | - | - | 18.09.2026 | 0,100 | Goldman Sachs | ||
| JH5SJC | Regeneron Pharmaceuticals Inc./OS/Call [600]/JPM | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,963 % | 0,709 | -0,014 | 4,559 | 18.12.2026 | 0,010 | JP Morgan | ||
| JY1K0Q | Regeneron Pharmaceuticals Inc./OS/Call [600]/JPMD | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,149 % | 0,790 | -0,029 | 7,382 | 21.08.2026 | 0,010 | JP Morgan | ||
| MK56VQ |  | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,375 % | 0,703 | -0,016 | 4,292 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KFB | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,844 % | 0,693 | -0,011 | 3,088 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5GYR | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,259 % | 0,738 | -0,024 | 5,853 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN1W1S | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 650,000 | 24,261 % | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN8XD5 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 650,000 | 12,547 % | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MN8XD7 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 650,000 | 15,344 % | - | - | - | 20.11.2026 | 0,100 | Morgan Stanley | |
| MN8XD6 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 650,000 | 14,943 % | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MR03T9 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 49,416 % | 0,691 | -0,009 | 2,468 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MR03TA | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,041 % | 0,694 | -0,013 | 3,533 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR3SHH | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 650,000 | 13,688 % | - | - | - | 15.01.2027 | 0,100 | Morgan Stanley | |
| MR3SQ3 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/MS | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | 650,000 | 10,672 % | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| SX5KQ8 | Regeneron Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,052 % | 0,746 | -0,220 | 6,285 | 18.09.2026 | 0,100 | Société Générale | ||
| FA53HN | Regeneron Pharmaceuticals Inc./OS/Call [600]/SOC | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,703 % | 0,709 | -0,146 | 4,491 | 18.12.2026 | 0,100 | Société Générale | ||
| VY416A | | Regeneron Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,112 % | 0,705 | -0,014 | 4,169 | 15.01.2027 | 0,010 | Vontobel | |
| VY42EA | | Regeneron Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,879 % | 0,700 | -0,015 | 4,436 | 18.12.2026 | 0,010 | Vontobel | |
| VY7X53 | | Regeneron Pharmaceuticals Inc./OS/Call [600]/VONT | - | - | 600,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,222 % | 0,750 | -0,022 | 6,368 | 18.09.2026 | 0,010 | Vontobel | |
| GW9F6S | Regeneron Pharmaceuticals Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,377 % | 0,682 | -0,011 | 3,321 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW9FC7 | Regeneron Pharmaceuticals Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,713 % | 0,690 | -0,008 | 2,627 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW9FC5 | Regeneron Pharmaceuticals Inc./OS/Call [610]/GOLDS | - | - | 610,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,749 % | 0,699 | -0,007 | 2,396 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW9CYW | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,667 % | 0,677 | -0,009 | 2,662 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW9D0P | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,744 % | 0,664 | -0,012 | 3,966 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW9D11 | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,277 % | 0,664 | -0,011 | 3,393 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW9D1X | Regeneron Pharmaceuticals Inc./OS/Call [620]/GOLDS | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,325 % | 0,689 | -0,008 | 2,435 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JH5XQJ | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPM | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,041 % | 0,667 | -0,015 | 4,891 | 18.12.2026 | 0,010 | JP Morgan | ||
| JE9D3J | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,539 % | 0,666 | -0,014 | 4,598 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE9D5P | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,715 % | 0,658 | -0,013 | 3,839 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY1K0L | Regeneron Pharmaceuticals Inc./OS/Call [620]/JPMD | - | - | 620,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,047 % | 0,721 | -0,032 | 8,701 | 21.08.2026 | 0,010 | JP Morgan | ||
| MK55RG | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,299 % | 0,651 | -0,016 | 4,658 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MK9KFC | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,749 % | 0,659 | -0,011 | 3,264 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5GYS | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,430 % | 0,666 | -0,025 | 6,776 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MR03TC | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 48,284 % | 0,674 | -0,010 | 2,552 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MR03TB | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,311 % | 0,653 | -0,013 | 3,749 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR3CEY | | Regeneron Pharmaceuticals Inc./OS/Call [625]/MS | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 53,823 % | 0,696 | -0,009 | 2,111 | 16.06.2028 | 0,010 | Morgan Stanley | |
| VY54GS | | Regeneron Pharmaceuticals Inc./OS/Call [625]/VONT | - | - | 625,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,113 % | 0,690 | -0,036 | 8,511 | 21.08.2026 | 0,010 | Vontobel | |
| GW9FC3 | Regeneron Pharmaceuticals Inc./OS/Call [630]/GOLDS | - | - | 630,000 | call | Regeneron Pharmaceuticals Inc. | - | 43,238 % | 0,680 | -0,008 | 2,462 | 16.06.2028 | 0,010 | Goldman Sachs |